What’s the problem with #BigPharma’s patent abuse? It blocks market entry of lower-cost, generic drugs and keeps #drugprices high, while patients foot the bill. Get the facts:
https://t.co/pLGeLrbloG
#BigPharma often files sham petitions with the FDA to slow generic drug approvals. Lawmakers need to stop this regulatory gridlock to help lower #drugprices for American patients.
https://t.co/pQBMq8uAMM
We advocate for smart policies that will bring down #drugprices and foster competition in the drug industry. Help us #StopPatentAbuse: https://t.co/d4x2gI15et
We must reform our patent system to ensure every American can afford the prescription medications they need to get and stay healthy.
https://t.co/G9X4B3fWUO
We believe that only true innovation should be rewarded with new patents. Lawmakers must stop #BigPharma from gaming the system at consumers’ expense.
https://t.co/mBgedQZUJG
Patent abuse and extension of regulatory monopolies keep #drugprices high and prevent timely access to better, affordable medicines for American patients. We must stop #BigPharma’s manipulation.
https://t.co/crlk1y0YHP
America’s drug pricing problem cannot be addressed without examining government-granted monopolies that prevent competition and slow innovation. Learn more to help #StopBigPharma:
https://t.co/97QHBQntnZ
Q: What’s the biggest problem with #BigPharma’s manipulation?
A: It leaves American patients unable to afford their prescriptions.
We need to #StopPatentAbuse.
DYK: Bad patents keep #drugprices high, slow innovation, and prevent timely access to better, affordable medicines that save and enhance patients’ lives? Get the facts: #PatentQualityWeek#PQW
#BigPharma’s strategies exploit weaknesses in the patent system’s police force to shield patents from attacks on patent quality and to extend their term artificially. Learn how:
#PatentQualityWeek#PQW
It’s #PatentQualityWeek! We fight abuses of the patent system that can extend government-granted monopolies illegitimately for years or even decades. Help stop patent abuse:
Improving patent quality is key to holding #BigPharma accountable for their abuse of the system. Join our Executive Director @MattCameronLane for an @RSI virtual panel to discuss this important issue:
https://t.co/5ldPI2gOF0